Advm stock news
News to Watch: Adverum Biotechnologies (NASDAQ:ADVM ... Mar 03, 2020 · Adverum Biotechnologies (NASDAQ:ADVM) spotted trading -26.77% off 52-week high price. On the other end, the stock has been noted 204.70% away from the low price over the last 52-weeks. The stock changed -1.20% to recent value of $12.31. Adverum Biotechnologies Gaining momentum in gene therapy. Adverum is a clinical-stage gene therapy company targeting unmet medical need in ocular and rare diseases. Learn More Adverum Biotechnologies Stock Quote. ADVM - Stock Price ...
9 Mar 2020 The ADVM stock was last observed hovering at around $13.30 in the last trading session, with the day's loss setting it -1.43% off its average
The one-year Adverum Biotechnologies Inc. stock forecast points to a potential upside of 30.99. The average equity rating for ADVM stock is currently 2.30, trading closer to a bullish pattern in the stock market. The market cap for the stock reached $985.33 million, with 83.01 million shares outstanding and 71.41 million shares in the current Adverum Biotechnologies Inc - NASDAQ:ADVM - Stock Quote ... View detailed financial information, real-time news, videos, quotes and analysis on Adverum Biotechnologies Inc (NASDAQ:ADVM). Explore commentary … ADVM - Adverum Biotechnlgs Stock Price - Barchart.com Adverum Biotechnologies (ADVM) delivered earnings and revenue surprises of 6.45% and -100.00%, respectively, for the quarter ended December 2019. Do the numbers hold clues to … Adverum Biotechnologies Inc (ADVM) Quote | Morningstar
Nov 06, 2019 · ADVM, Adverum Biotechnologies - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines
View the latest Adverum Biotechnologies Inc. (ADVM) stock price, news, historical charts, analyst ratings and financial information from WSJ. Adverum Biotechnologies, Inc. Common Stock (ADVM) Stock ... Adverum Biotechnologies, Inc. Common Stock (ADVM) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. ADVM Stock News - Fidelity Apr 02, 2020 · Adverum Biotechnologies, Inc. (ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ocular and rare diseases, today announced the closing of its previously announced underwritten public offering of 10,925,000 shares of its common stock at a public offering price of $13.75 per share, which included the full exercise of
8 analysts have issued twelve-month target prices for Adverum Biotechnologies' shares. Their forecasts range from $13.00 to $21.00. On average, they expect
ADVM Stock Price Quote & News - Adverum Biotechnologies ... View the real-time ADVM price chart on Robinhood and decide if you want to buy or sell commission-free. Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Adverum Biotechnologies against related stocks people have also bought like PLUG, CRSP, CPRX, and FCEL. 1,991 people own Adverum Biotechnologies on Robinhood on April 4, 2020. ADVM Stock Quote - Adverum Biotechnologies, Inc. Stock ... ADVM stock quote, chart and news. Get Adverum Biotechnologies, Inc.'s stock price today. ADVM News Today (Adverum Biotechnologies) | MarketBeat What's going on at Adverum Biotechnologies (NASDAQ:ADVM)? View breaking news headlines for ADVM stock from trusted media outlets at MarketBeat.
Find the latest Adverum Biotechnologies, Inc. (ADVM) stock quote, history, news and other vital information to help you with your stock trading and investing.
ADVM Adverum Biotechnologies, Inc — Stock Price and ...
Stock analysis for Adverum Biotechnologies Inc (ADVM:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and